West Announces Fourth-Quarter And Full-Year 2021 Results.

SEES FY EARNINGS PER SHARE $9.20 TO $9.35.
SEES FY SALES $3.05 BILLION TO $3.075 BILLION.
Q4 SALES ROSE 26 PERCENT TO $730.8 MILLION.
Q4 EARNINGS PER SHARE $1.93.
Q4 EARNINGS PER SHARE VIEW $1.92, REVENUE VIEW $710.2 MILLION -- REFINITIV IBES DATA.
FY2022 EARNINGS PER SHARE VIEW $9.06, REVENUE VIEW $3.07 BILLION -- REFINITIV IBES DATA.
QTRLY ADJUSTED-DILUTED EPS OF $2.04.
WEST PHARMACEUTICAL SERVICES- 2022 NET SALES GUIDANCE INCLUDES ESTIMATED FULL-YEAR 2022 HEADWIND OF $70 MILLION BASED ON CURRENT FOREIGN EXCHANGE RATES.